gemfibrozil has been researched along with Fatty Liver in 3 studies
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sashidhara, KV | 1 |
| Kumar, M | 1 |
| Sonkar, R | 1 |
| Singh, BS | 1 |
| Khanna, AK | 1 |
| Bhatia, G | 1 |
| Angulo, P | 1 |
| Dufour, JF | 1 |
| Oneta, CM | 1 |
2 reviews available for gemfibrozil and Fatty Liver
| Article | Year |
|---|---|
Current best treatment for non-alcoholic fatty liver disease.
Topics: Antioxidants; Chromans; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Fatty L | 2003 |
[Alcoholic and non-alcoholic steatohepatitis].
Topics: Alcoholism; Biopsy; Cholagogues and Choleretics; Diagnosis, Differential; Fatty Liver; Fatty Liver, | 2004 |
1 other study available for gemfibrozil and Fatty Liver
| Article | Year |
|---|---|
Indole-based fibrates as potential hypolipidemic and antiobesity agents.
Topics: Animals; Anti-Obesity Agents; Bile Acids and Salts; Butyrates; Dietary Fats; Fatty Liver; Feces; Fee | 2012 |